Erlotinib Completed Phase 1 Trials for Unspecified Adult Solid Tumor, Protocol Specific Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00042809Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors
NCT00126620Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00276575Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors
NCT00320073Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors